高薬理活性原薬（HPAPI）の世界市場規模は、2028年までに388億4,000万米ドルに達する見込みです。2021年から2028年までのCAGRは8.4%で拡大すると予想されています。市場を牽引するのは、標的療法への注目の高まりと、癌治療薬の需要の急増です。
癌の罹患率の上昇は、高薬理活性原薬市場を牽引すると予想される主な要因です。WHOによると、癌は2番目に大きな死因で、2018年には960万人以上の死亡者を出しており、たばこの使用は癌死亡者の22％を占めています。CDCによると、喫煙、肥満、飲酒などのライフスタイルの変化や、太陽や日焼けベッドからの紫外線への暴露などのリスク要因が、この病気の全体的な負担になっているとのことです。さらに、癌治療にかかる費用は、2020年末までに1,740億米ドルに達すると予想されており、これが市場の成長を加速させると考えられています。
COVID-19治療用のレムデシビルなどの抗ウイルス薬の需要の増加は、強力な抗ウイルスHPAPIの需要に拍車をかけています。 COVID-19によるサプライヤーのダイナミクスの変化と、HPAPIなどの医薬品原料に対する政府の注目の高まりが市場を牽引しています。
日本と中国は、HPAPIの製造に携わる多数のバイオ企業が存在する主要な国です。武田薬品工業社や三共社などの大手企業の存在が、これらの国におけるバイオ由来のAPIの開発を後押ししています。さらに、バイオテクノロジー分野の成長は、バイオテクノロジーやバイオ医薬品分野への投資が多いことに起因しています。これにより、癌などの病気の治療に役立つ新しい分子の開発が可能になります。
主要プ企業は、生産能力を高め、提供する製品のアウトリーチを促進するために様々な戦略を活用しています。例えば、2020年7月、CordenPharma International社は、ペプチド原薬の需要増に対応するため、コロラド州のペプチド製造ユニットの拡張を発表しました。この拡張により、同社の成長が可能となり、増収に貢献することになります。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.2.1 Information procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.5 Region-wise Market Calculation
1.5.1 Region-Wise Market: Base Estimates
1.5.2 Global Market: CAGR Calculation
1.6 Region-based Segment Share Calculation
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.8.1 Primary interview breakup
1.8.1.1 Data for primary interviews, by sources
1.8.1.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 High Potency Active Pharmaceutical Ingredients Market Variables, Trends & Scope
3.1 Market Driver Analysis
3.1.1 Rising prevalence of cancer
3.1.2 Growth of targeted therapies
3.1.3 Increasing application of HPAPIs
3.1.4 Market Restraint Analysis
3.1.4.1 Large investments and very stringent safety and handling specifications associated with the production of HPAPIs
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Regulatory Scenario
3.5 Pricing Analysis
3.6 Impact of generic drugs on the overall market
3.6.1 High Potency Active Pharmaceutical Ingredients - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6.2 Industry Analysis - Porter's
Chapter 4 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Product, 2017 - 2028 (USD Million)
4.1 Product Market Share Analysis, 2020 & 2028
4.1.1 Synthetic
4.1.1.1 Synthetic market estimates and forecasts, 2017 - 2028 (USD Million)
4.1.2 Biotech
4.1.2.1 Biotech market estimates and forecasts, 2017 - 2028 (USD Million)
Chapter 5 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Manufacturer Type, 2017 - 2028 (USD Million)
5.1 Manufacturer Type Market Share Analysis, 2020 & 2028
5.1.1 In-house
5.1.1.1 In-house market estimates and forecasts, 2017 - 2028 (USD Million)
5.1.2 Outsourced
5.1.2.1 Outsourced market estimates and forecasts, 2017 - 2028 (USD Million)
Chapter 6 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Drug Type, 2017 - 2028 (USD Million)
6.1 Drug Type Market Share Analysis, 2020 & 2028
6.1.1 Innovative
6.1.1.1 Innovative market estimates and forecasts, 2017 - 2028 (USD Million)
6.1.2 Generic
6.1.2.1 Generic market estimates and forecasts, 2017 - 2028 (USD Million)
Chapter 7 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Application, 2017 - 2028 (USD Million)
7.1 Application Market Share Analysis, 2020 & 2028
7.1.1 Oncology
7.1.1.1 Oncology market estimates and forecasts, 2017 - 2028 (USD Million)
7.1.2 Hormonal disorders
7.1.2.1 Hormonal disorders market estimates and forecasts, 2017 - 2028 (USD Million)
7.1.3 Glaucoma
7.1.3.1 Glaucoma market estimates and forecasts, 2017 - 2028 (USD Million)
7.1.4 Other Applications
7.1.4.1 Other applications market estimates and forecasts, 2017 - 2028 (USD Million)
Chapter 8 High Potency Active Pharmaceutical Ingredients Market: Segment Analysis, By Region, 2017 - 2028 (USD Million)
8.1 High Potency Active Pharmaceutical Ingredients Market, Market Share by Region, 2020 & 2028
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.7 Russia
8.1.2.7.1 Russia market estimates and forecast, 2017 - 2028 (USD Million)
8.1.2.8 Switzerland
8.1.2.8.1 Switzerland market estimates and forecast, 2017 - 2028 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2017 - 2028 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2017 - 2028 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4.5 Colombia
8.1.4.5.1 Colombia market estimates and forecast, 2017 - 2028 (USD Million)
8.1.4.6 Chile
8.1.4.6.1 Chile market estimates and forecast, 2017 - 2028 (USD Million)
8.1.5 Middle East and Africa
8.1.6 Middle East & Africa market estimates and forecast, 2017 - 2028 (USD Million)
8.1.6.1 South Africa
8.1.6.1.1 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 9 Competitive Landscape
9.1 Recent developments & impact analysis, by key market participants
9.1.1 Ansoff matrix
9.2 Major deals & strategic alliances analysis
9.2.1 Joint Ventures
9.2.2 Licensing and Partnerships
9.2.3 Technological Collaborations
9.3 Company/Competition Categorization
9.4 Vendor Landscape
9.4.1 List of key distributors and channel partners
9.4.2 Key customers
9.5 Public Companies
9.5.1 Company market position analysis
9.6 Private Companies
9.6.1 List of key emerging companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 BASF SE
9.7.1.1 Company Overview
9.7.1.2 Financial Performance
9.7.1.3 Product Benchmarking
9.7.1.4 Strategic Initiatives
9.7.2 CordenPharma International
9.7.2.1 Company Overview
9.7.2.2 Product Benchmarking
9.7.2.3 Strategic Initiatives
9.7.3 Dr. Reddy’s Laboratories Ltd.
9.7.3.1 Company Overview
9.7.3.2 Financial Performance
9.7.3.3 Product Benchmarking
9.7.3.4 Strategic Initiatives
9.7.4 Carbogen Amcis AG
9.7.4.1 Company Overview
9.7.4.2 Financial Performance
9.7.4.3 Product Benchmarking
9.7.4.4 Strategic Initiatives
9.7.5 Pfizer Inc.
9.7.5.1 Company Overview
9.7.5.2 Financial Performance
9.7.5.3 Product Benchmarking
9.7.5.4 Strategic Initiatives
9.7.6 Sun Pharmaceutical Industries Ltd.
9.7.6.1 Company Overview
9.7.6.2 Financial Performance
9.7.6.3 Product Benchmarking
9.7.6.4 Strategic Initiatives
9.7.7 Teva Pharmaceutical Industries Ltd.
9.7.7.1 Company Overview
9.7.7.2 Financial Performance
9.7.7.3 Product Benchmarking
9.7.7.4 Strategic Initiatives
9.7.8 Albany Molecular Research Inc.
9.7.8.1 Company Overview
9.7.8.2 Product Benchmarking
9.7.8.3 Strategic Initiatives
9.7.9 Sanofi
9.7.9.1 Company Overview
9.7.9.2 Financial Performance
9.7.9.3 Product Benchmarking
9.7.9.4 Strategic Initiatives
9.7.10 Merck & Co., Inc.
9.7.10.1 Company Overview
9.7.10.2 Financial Performance
9.7.10.3 Product Benchmarking
9.7.10.4 Strategic Initiatives
9.7.11 Novartis AG
9.7.11.1 Company Overview
9.7.11.2 Financial Performance
9.7.11.3 Product Benchmarking
9.7.11.4 Strategic Initiatives
9.7.12 F. Hoffmann-La Roche Ltd.
9.7.12.1 Company Overview
9.7.12.2 Financial Performance
9.7.12.3 Product Benchmarking
9.7.12.4 Strategic Initiatives
9.7.13 Bristol-Myers Squibb Company
9.7.13.1 Company Overview
9.7.13.2 Financial Performance
9.7.13.3 Product Benchmarking
9.7.13.4 Strategic Initiatives
9.7.14 Boehringer Ingelheim GmbH
9.7.14.1 Company Overview
9.7.14.2 Financial Performance
9.7.14.3 Product Benchmarking
9.7.14.4 Strategic Initiatives
9.7.15 Lonza
9.7.15.1 Company Overview
9.7.15.2 Financial Performance
9.7.15.3 Product Benchmarking
9.7.15.4 Strategic Initiatives
9.7.16 Cipla Inc.
9.7.16.1 Company Overview
9.7.16.2 Financial Performance
9.7.16.3 Product Benchmarking
9.7.16.4 Strategic Initiatives
List of Tables
TABLE 1 Estimated new cancer case statistics 2016 & 2018
TABLE 2 Global High potency active pharmaceutical ingredients market, by region, 2017 - 2028 (USD Million)
TABLE 3 Global High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 4 Global High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 5 Global High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 6 Global High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 7 North America High potency active pharmaceutical ingredients market, by country, 2017 - 2028 (USD Million)
TABLE 8 North America High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 9 North America High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 10 North America High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 11 North America High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 12 U.S. High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 13 U.S. High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 14 U.S. High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 15 U.S.High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 16 Canada High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 17 Canada High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 18 Canada High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 19 Canada High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 20 Europe High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 21 Europe High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 22 Europe High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 23 Europe High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 24 Europe High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 25 U.K. High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 26 U.K. High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 27 U.K. High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 28 U.K. High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 29 Germany High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 30 Germany High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 31 Germany High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 32 Germany High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 33 Spain High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 34 Spain High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 35 Spain High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 36 Spain High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 37 France High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 38 France High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 39 France High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 40 France High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 41 Italy High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 42 Italy High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 43 Italy High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 44 Italy High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 45 Russia High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 46 Russia High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 47 Russia High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 48 Russia High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 49 Switzerland High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 50 Switzerland High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 51 Switzerland High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 52 Switzerland High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 53 Asia Pacific High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 54 Asia Pacific High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 55 Asia Pacific High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 56 Asia Pacific High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 57 Asia Pacific High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 58 Japan High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 59 Japan High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 60 Japan High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 61 Japan High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 62 China High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 63 China High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 64 China High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 65 China High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 66 India High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 67 India High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 68 India High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 69 India High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 70 Latin America High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 71 Latin America High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 72 Latin America High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 73 Latin America High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 74 Latin America High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 75 Brazil High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 76 Brazil High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 77 Brazil High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 78 Brazil High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 79 Mexico High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 80 Mexico High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 81 Mexico High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 82 Mexico High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 83 Argentina High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 84 Argentina High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 85 Argentina High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 86 Argentina High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 87 Chile High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 88 Chile High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 89 Chile High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 90 Chile High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 91 Colombia High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 92 Colombia High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 93 Colombia High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 94 Colombia High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 95 MEA High potency active pharmaceutical ingredients market, 2017 - 2028 (USD Million)
TABLE 96 MEA High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 97 MEA High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 98 MEA High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 99 MEA High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
TABLE 100 South Africa High potency active pharmaceutical ingredients market, by product, 2017 - 2028 (USD Million)
TABLE 101 South Africa High potency active pharmaceutical ingredients market, by drug type, 2017 - 2028 (USD Million)
TABLE 102 South Africa High potency active pharmaceutical ingredients market, by manufacturer type, 2017 - 2028 (USD Million)
TABLE 103 South Africa High potency active pharmaceutical ingredients market, by application, 2017 - 2028 (USD Million)
List of Figures
FIG. 1 High Potency Active Pharmaceutical Ingredients (HPAPIs) market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Primary interviews, by sources
FIG. 10 Primary interviews, by region
FIG. 11 High potency active pharmaceutical ingredients market summary
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Estimated number of cancer cases (5 year) worldwide
FIG. 14 New cases of cancer worldwide (2018)
FIG. 15 High potency active pharmaceutical ingredients market restraint impact
FIG. 16 Penetration and growth prospect mapping
FIG. 17 User perspective analysis
FIG. 18 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 19 Porter’s five forces analysis
FIG. 20 High potency active pharmaceutical ingredients product outlook: key takeaways
FIG. 21 High potency active pharmaceutical ingredients market: product movement analysis
FIG. 22 Synthetic market, 2017 - 2028 (USD Million)
FIG. 23 Biotech market, 2017 - 2028 (USD Million)
FIG. 24 High potency active pharmaceutical ingredients market type of manufacturer outlook: Key takeaways
FIG. 25 High potency active pharmaceutical ingredients market: type of manufacturer movement analysis
FIG. 26 In-house market, 2017 - 2028 (USD Million)
FIG. 27 Outsourced market, 2017 - 2028 (USD Million)
FIG. 28 High potency active pharmaceutical ingredients market application outlook: key takeaways
FIG. 29 High potency active pharmaceutical ingredients market: drug type movement analysis
FIG. 30 Innovative market, 2017 - 2028 (USD Million)
FIG. 31 Generic market, 2017 - 2028 (USD Million)
FIG. 32 High potency active pharmaceutical ingredients market application outlook: key takeaways
FIG. 33 High potency active pharmaceutical ingredients market: application movement analysis
FIG. 34 Oncology market, 2017 - 2028 (USD Million)
FIG. 35 Hormonal disorders market, 2017 - 2028 (USD Million)
FIG. 36 Glaucoma market, 2017 - 2028 (USD Million)
FIG. 37 Other applications market, 2017 - 2028 (USD Million)
FIG. 38 Regional marketplace: key takeaways
FIG. 39 Regional outlook, 2020 & 2028
FIG. 40 North America
FIG. 41 North America. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 42 U.S.
FIG. 43 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 44 Canada
FIG. 45 Canada market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 46 Europe
FIG. 47 Europe market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 48 U.K.
FIG. 49 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 50 Germany
FIG. 51 Germany market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 52 France
FIG. 53 France market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 54 Spain
FIG. 55 Spain market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 56 Italy
FIG. 57 Italy market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 58 Russia
FIG. 59 Russia market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 60 Switzerland
FIG. 61 Switzerland market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 62 Asia Pacific
FIG. 63 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 64 Japan
FIG. 65 Japan market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 66 China
FIG. 67 China market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 68 India
FIG. 69 India market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 70 Latin America
FIG. 71 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 72 Brazil
FIG. 73 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 74 Mexico
FIG. 75 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 76 Argentina
FIG. 77 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 78 Colombia
FIG. 79 Colombia market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 80 Chile
FIG. 81 Chile market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 82 Middle East & Africa
FIG. 83 MEA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 84 South Africa
FIG. 85 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 86 Ansoff Matrix
FIG. 87 Strategy mapping
FIG. 88 Company/Competition Categorization
FIG. 89 Heat Map Analysis
FIG. 90 Regional Network Map
